title: Authors' reply to Green and colleagues.
authors.affiliation: West Midlands Centre for Adverse Drug Reactions, City Hospital, Birmingham B18 7QH, UK r.e.ferner@bham.ac.uk.
authors.forename: Robin E
authors.initials: RE
authors.lastname: Ferner
authors.affiliation: Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai 400012, India.
authors.forename: Nithya J
authors.initials: NJ
authors.lastname: Gogtay
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D006801:Humans; D016778:Malaria, Falciparum / Q000517:prevention & control*; D015767:Mefloquine / Q000627:therapeutic use*; D008889:Military Personnel
chemical_list: D000962:Antimalarials; D015767:Mefloquine